M
Marinomed Biotech AG
VSE:MARI
Marinomed Biotech AG
VSE:MARI
Price:
13.9
EUR
-0.71%
Market Closed
Market Cap:
€25.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
|
Carter Bankshares Inc
F:6NH
|
US |
|
CAP XX Ltd
LSE:CPX
|
AU |
|
Hua Nan Financial Holdings Co Ltd
TWSE:2880
|
TW |
|
A
|
Alujain Corp
SAU:2170
|
SA |
|
Advanced Share Registry Ltd
ASX:ASW
|
AU |
|
P
|
PMPG Polskie Media SA
WSE:PGM
|
PL |
|
D
|
Duniec Bros Ltd
TASE:DUNI
|
IL |
|
N
|
Nestle SA
BMV:NESNN
|
CH |
|
NTR Holding A/S
CSE:NTR B
|
DK |
|
B
|
Banco Bradesco SA
SWB:BREC
|
BR |
Cash Flow Statement
Cash Flow Statement
Marinomed Biotech AG
Marinomed Biotech AG
Currency: EUR
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(12)
|
0
|
(3)
|
0
|
(7)
|
0
|
(10)
|
0
|
(6)
|
0
|
(10)
|
0
|
(6)
|
0
|
(10)
|
0
|
(6)
|
(10)
|
0
|
(7)
|
0
|
(18)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
7
|
0
|
1
|
0
|
2
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
2
|
0
|
3
|
0
|
1
|
2
|
0
|
2
|
0
|
9
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
|
| Change in Working Capital |
1
|
(7)
|
0
|
(11)
|
(3)
|
(8)
|
0
|
(6)
|
(2)
|
(5)
|
(3)
|
(2)
|
(1)
|
2
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
1
|
(3)
|
|
| Cash from Operating Activities |
(4)
N/A
|
(7)
-60%
|
0
N/A
|
(11)
N/A
|
(8)
+30%
|
(8)
-2%
|
0
N/A
|
(6)
N/A
|
(7)
-13%
|
(11)
-54%
|
(12)
-13%
|
(7)
+40%
|
(5)
+33%
|
(2)
+56%
|
(2)
+5%
|
(4)
-86%
|
(5)
-38%
|
(5)
-1%
|
(6)
-7%
|
(5)
+19%
|
(5)
-21%
|
(4)
+24%
|
(3)
+40%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
0
|
0
|
0
|
(2)
|
0
|
(4)
|
0
|
(4)
|
0
|
(5)
|
0
|
(1)
|
0
|
(1)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
0
|
(0)
|
0
|
(2)
|
(0)
|
(2)
|
0
|
(2)
|
0
|
(0)
|
0
|
1
|
0
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+0%
|
0
N/A
|
(2)
N/A
|
(2)
-40%
|
(2)
+25%
|
0
N/A
|
(2)
N/A
|
(4)
-60%
|
(4)
-10%
|
(5)
-8%
|
(2)
+48%
|
(1)
+63%
|
(1)
+40%
|
(0)
+46%
|
(0)
+8%
|
(0)
+25%
|
(0)
-1%
|
(0)
+19%
|
(0)
+25%
|
(0)
N/A
|
(0)
+96%
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
18
|
0
|
22
|
0
|
22
|
0
|
8
|
0
|
8
|
0
|
2
|
0
|
10
|
0
|
8
|
7
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Other |
(0)
|
20
|
0
|
36
|
(2)
|
16
|
0
|
0
|
(0)
|
0
|
(0)
|
1
|
(0)
|
7
|
0
|
7
|
0
|
0
|
(9)
|
0
|
(1)
|
(1)
|
2
|
|
| Cash from Financing Activities |
0
N/A
|
20
+8 448%
|
0
N/A
|
36
N/A
|
20
-43%
|
16
-19%
|
0
N/A
|
0
N/A
|
8
+222 278%
|
8
+1%
|
8
0%
|
9
+10%
|
2
-73%
|
9
+287%
|
10
+8%
|
9
-9%
|
8
-14%
|
(0)
N/A
|
(1)
-424%
|
(1)
+1%
|
(1)
+23%
|
(0)
+52%
|
2
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(4)
N/A
|
13
N/A
|
0
N/A
|
23
N/A
|
10
-55%
|
7
-34%
|
0
N/A
|
(9)
N/A
|
(3)
+67%
|
(7)
-146%
|
(9)
-25%
|
(1)
+90%
|
(3)
-310%
|
7
N/A
|
8
+17%
|
5
-34%
|
2
-53%
|
(6)
N/A
|
(7)
-19%
|
(6)
+17%
|
(6)
-13%
|
(4)
+29%
|
(1)
+80%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(7)
-52%
|
0
N/A
|
(11)
N/A
|
(10)
+8%
|
(8)
+22%
|
(4)
+53%
|
(6)
-65%
|
(11)
-79%
|
(11)
+2%
|
(17)
-57%
|
(7)
+57%
|
(6)
+20%
|
(2)
+63%
|
(3)
-45%
|
(4)
-22%
|
(5)
-44%
|
(6)
-3%
|
(6)
0%
|
(5)
+17%
|
(5)
-18%
|
(4)
+24%
|
(3)
+40%
|
|
Switch to:
Switch to:
See Also
Discover More
